E-DRUG Archives (by thread)

  • [e-drug] RFI: Formulas for compounding of Essential drugs? (3), ibnsinaacademy
  • [e-drug] RFI: Formulas for compounding of Essential drugs? (4), Maronda Benjamin
  • [e-drug] Novartis files a fresh case (2), NOVARTIS
  • [e-drug] Introducing Essential Health Links at AED-SATELLIFE, Leela McCullough
  • [e-drug] Course on Drug and Therapeutics Committees, Uganda, 6-19 Jan 2008, Paul Waako
  • [e-drug] BBC: Fake malaria drugs recalled in Kenya (2), Jayesh M Pandit
  • [e-drug] WHO Model List of Essential Medicines for Children, Suzanne Hill
  • [e-drug] Review of interventions to reduce loss to follow-up from ART, Gesine Meyer-Rath
  • [e-drug] Medicine pricing studies in Africa, Wilbert Bannenberg
  • [e-drug] US NIH grants MMV over $5,000,000 for malaria research, Jaya Banerji
  • [e-drug] Novartis files a fresh case (3), Dr Gopal Dabade
  • [e-drug] European Commission position on compulsory licensing, "Jérôme Martin"
  • [e-drug] Nimesulide put under focused pharmacovigilance programme in India, Bindu Raol
  • [e-drug] Towards centralized and transparent marketing authorizations, Maria Font
  • [e-drug] Nimesulide under focused pharmacovigilance in India (3), ikhafa steve iruedo
  • [e-drug] Answer of Thai Minister of Health to EU Commissioner Mandelson, Alexandra HEUMBER
  • [e-drug] Pharmacovigilance in developing countries, E-Drug
  • [e-drug] RFI: global database on medicines compendia, Blanca Arguello Magaz
  • [e-drug] Pfizer, FDA warn of potential carcinogen impurity in Viracept, Leela McCullough
  • [e-drug] TB field diagnostics conference MSF Cape Town 7 Nov, Buddhima Lokuge
  • [e-drug] Extended release formulations of ofloxacin?, ikhafa steve iruedo
  • [e-drug] Vacancy: PEPFAR - Supply Chain Management Systems (SCMS), Lourdes Loch-Martinez
  • [e-drug] Vacancy - ART logistics adviser PEPFAR Namibia, Lourdes Loch-Martinez
  • [e-drug] Vacancy - Laboratory logistics adviser PEPFAR Namibia, Lourdes Loch-Martinez
  • [e-drug] Vacancy: PEPFAR Botswana lead resident advisor, Lourdes Loch-Martinez
  • [e-drug] WHO Database of national Essential Medicines Lists, Hill, Suzanne
  • [e-drug] Medicine prices, availability and affordability in Yemen, Marg Ewen
  • [e-drug] RFI: Seeking hospital pharmacy contacts, S.J. (Satu) Siiskonen
  • [e-drug] Independent or integrated Drug Regulatory Authority?, Wilbert Bannenberg
  • [e-drug] Stavudine in Paediatric ART?, K.F.Steinhausen
  • [e-drug] Independent or integrated Drug Regulatory Authority? (4), Moses N.P.Batema Jr.
  • [e-drug] Pakistan Supreme Court orders survey on hike in drug prices (2), Nadeem Alamgir
  • [e-drug] Extended release formulations of ofloxacin? (3), Andrew Herxheimer
  • [e-drug] Preparing for WHO IGWG? - here are some useful documents, Ellen T HOEN
  • [e-drug] Stavudine in Paediatric ART? (3), AbdurRafiu A. Idris
  • [e-drug] The Health Journey - New Publication from Intl. HIV/AIDS Alliance, Carolyn Green
  • [e-drug] RFI: Hospital pharmaceutical procurement in Sweden and Canada?, Pauline Norris
  • [e-drug] Call for Proposals: Accessing Patented Knowledge for Innovation, Leela McCullough
  • [e-drug] IV Ethanol or fomepizole for methanol poisoning?, ozma fazal
  • [e-drug] Price regulation of essential medicines in India, E-Drug
  • [e-drug] WHO: QCLs may submit expression of interest for prequalification, E-drug
  • [e-drug] Why is lovastatin not registered in UK?, Ruwan Chandana
  • [e-drug] Can we standardise the pharmaceuticals' mark-up on cost?, Gamal Khalafalla Mohammed
  • [e-drug] Why is lovastatin not registered in UK? (2), Valeria Frighi
  • [e-drug] 10th Edition of Untangling the Web (September Revision), Karen Day
  • [e-drug] Extended release formulations of ofloxacin? (4), James B. Russo
  • [e-drug] Stavudine in Paediatric ART? (4), K.F.Steinhausen
  • [e-drug] 200 life-saving drugs to be cheaper - news from India, Dr Gopal Dabade
  • [e-drug] ARV Drug Supply Management Training, Annelize Jooste
  • [e-drug] Splitting of fixed dose combination tablets?, Chengetanai Mangoro
  • [e-drug] ARV Drug Supply Mangt course in low resource settings, Sunitha Srinivas
  • [e-drug] Training Course on Promoting Rational Drug Use in the Community, Sunitha Srinivas
  • [e-drug] Some practical questions from the field, ozma fazal
  • [e-drug] Splitting of FDC tablets (2), Susan Walters
  • [e-drug] Can we standardise the pharmaceuticals' mark-up on cost? (4), chandrasekar kalyanram
  • [e-drug] New Report Exposes Global Lack of Access to Essential Analgesics, Jo Pratt
  • [e-drug] MSH/RPM Plus and GDF Union Workshop Annoucement, Marie-Reine Maroun
  • [e-drug] Can we standardise the pharmaceuticals' mark-up on cost? (5), Alemayehu Lemma
  • [e-drug] Can we standardise the pharmaceuticals' mark-up on cost? (6), Libby Levison
  • [e-drug] Can we standardise the pharmaceuticals' mark-up on cost? (7), JBRusso
    • Mail converted by MHonArc 2.6.8